Hi, all.
I'm just wondering if anyone here who has ME/CFS has also been found to be positive for glucose-6-phosphate dehydrogenase deficiency (G6PDD).
This is starting to be of some interest in autism, particularly in people of Middle Eastern or African descent, in which
there is a greater prevalence of G6PDD, probably because malaria selected for people who had this genetic variation
in the past.
This is the most common genetic mutation in the human population. It causes red blood cells to be less able to
recycle their glutathione, and can thus lead to early death of these cells. This is normally a disadvantage, but the benefit in malaria is that the malaria
parasites inhabit the red blood cells and depend on the antioxidant system in the red blood cells for their survival. GDPDD would hamper control of oxidative stress,
and that could help to kill the red cells in which the malaria parasites reside, and hence to knock out the parasites as well.
Given that I believe that both ME/CFS and autism begin in most cases with depletion of the chemically reduced form
of glutathione, and that red blood cells are normally net producers and exporters of glutathione, it would make
sense from a theoretical point of view that having G6PDD would tend to increase the susceptibility to developing
ME/CFS or autism.
I don't see anything about this in the ME/CFS research literature, and am wondering if this connection really shows up in the ME/CFS population.
Thanks.
Rich
I'm just wondering if anyone here who has ME/CFS has also been found to be positive for glucose-6-phosphate dehydrogenase deficiency (G6PDD).
This is starting to be of some interest in autism, particularly in people of Middle Eastern or African descent, in which
there is a greater prevalence of G6PDD, probably because malaria selected for people who had this genetic variation
in the past.
This is the most common genetic mutation in the human population. It causes red blood cells to be less able to
recycle their glutathione, and can thus lead to early death of these cells. This is normally a disadvantage, but the benefit in malaria is that the malaria
parasites inhabit the red blood cells and depend on the antioxidant system in the red blood cells for their survival. GDPDD would hamper control of oxidative stress,
and that could help to kill the red cells in which the malaria parasites reside, and hence to knock out the parasites as well.
Given that I believe that both ME/CFS and autism begin in most cases with depletion of the chemically reduced form
of glutathione, and that red blood cells are normally net producers and exporters of glutathione, it would make
sense from a theoretical point of view that having G6PDD would tend to increase the susceptibility to developing
ME/CFS or autism.
I don't see anything about this in the ME/CFS research literature, and am wondering if this connection really shows up in the ME/CFS population.
Thanks.
Rich